India Approves Qdenga Dengue Vaccine Amid Rising Cases
India has approved the Qdenga vaccine to combat rising dengue fever cases, particularly in high-risk regions like Karnataka. Medical experts emphasize that the vaccine, combined with mosquito control, is a vital tool for reducing hospitalizations.
Why it matters
Vaccine approval is a major public health milestone for managing endemic tropical diseases that strain healthcare systems.
Bengaluru: The Drugs Controller General of India (DCGI) has granted approval for Qdenga, a dengue vaccine aimed at lowering the risk of infection, severe disease, and hospitalisation. Local medical professionals have praised the approval as a major advancement in public health, particularly during peak periods of dengue transmission.
Data from the Health and Family Welfare Department revealed fluctuations in dengue cases in Karnataka, with reports indicating a rise from 93 cases in the first week of July to 129 the following week, and then surging further to 229 cases in the third week.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in